FILTER
FILTERED INTERVIEW RESULTS
Fabiano Machion
GENERAL MANAGER SOUTH AMERICA, NEWPORT TANK
Newport Tank was acquired by Shanghai Junzheng Logistics, and will adapt its strategy with an eye to the future.
Eugenio Manzano
EXECUTIVE DIRECTOR, POCHTECA
Pochteca talks about its commitment to promoting equality in the workplace and supporting the communities in which the company operates.
Jarl Kåreson Hakvåg
CHARTERING SOUTH AMERICA AC/USG, ODFJELL TANKERS
Odfjell is the second largest specialized tanker company for chemical transportation in the world.
Edmundo Puentes
GENERAL MANAGER, OXIQUIM
"In the recent years, Oxiquim’s terminal and logistics business has grown significantly. Approximately 70% of LPG imported into Chile is handled at Oxiquim’s terminals, and we are currently in the process of building a new LPG terminal in Mejillones.”
Dennys Spencer
DIRECTOR, AMBIPAR RESPONSE
Ambipar Response is expanding its Latin American presence.
Rogério Wehmuth & Andressa Wehmuth
OWNER AND DIRECTOR & LATIN AMERICA GENERAL MANAGER, QUIMISA
Quimisa discusses its plans to expand geographically and incorporate greater sustainability into its operations.
Juan Diego Mejia Mejia
PRESIDENT, ESENTTIA
Esenttia looks to generate value for the plastics industry through its diverse portfolio of high quality products and solutions.
Manfredo Rübens
PRESIDENT SOUTH AMERICA, BASF
BASF is pushing digitalization as part of its strategy to support its growing presence in South America.
Guillermo Laborato
PRESIDENT, LATIN AMERICA SOUTH, BRENNTAG
Despite a challenging economic environment, Brenntag’s Latin American operations continue to experience growth.
Diogo Mac Cord de Faria
NATIONAL SECRETARY OF INFRASTRUCTURE DEVELOPMENT, MINISTRY OF THE ECONOMY, GOVERNMENT OF BRAZIL
The Government of Brazil looks to reduce logistics bottlenecks as part of its wider strategy to grow its GDP from 1.7% to 4% by 2022.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
